Supplementary Table 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma (original) (raw)

paper cover icon

Supplementary Table 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma

Kristi ElkinsKristi Elkins

Abstract

XLSX file - 30K, IC50 concentrations and CD22 expression levels for cell lines.

Kristi Elkins hasn't uploaded this paper.

Let Kristi know you want this paper to be uploaded.

Ask for this paper to be uploaded.